Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
Q1 2026 earnings • released • EPS beat +70.18% • Revenue beat +64.58%
See results
MRNA:NASDAQ
Moderna Inc
US$45.37
-1.24%
(-0.57) 1D
US$45.17
-0.44% (-0.20)
After hours
Closed: 1 મે, 04:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRNA...
ખોલો
US$46.64
High
US$48.40
Low
US$43.68
Mkt. cap
૧૭.૯૯ અબજ
Avg. vol.
૬૩.૭૩ લાખ
Volume
૧.૦૨ કરોડ
52-wk high
US$59.55
52-wk low
US$22.28
EPS
-US$7.25
Beta
૧.૩૩
Shares outstanding
૩૯.૬૬ કરોડ
No. of employees
૫ હજાર
News stories
From sources across the web
પ્રોફાઇલ
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern". The company's commercial products are the Moderna COVID-19 vaccine, marketed as Spikevax and a respiratory syncytial virus vaccine, marketed as Mresvia. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines. Wikipedia
About Moderna Inc
CEOસ્ટેફન બૈન્સલ
Employees4.7 હજાર
Foundedસપ્ટે 2010
Headquarters-
Sector-
Websitemodernatx.com
Last report
1 મે, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-૧.૧૮/ (-૩.૯૬ est.)USD
+70.18%beat
Revenue / Estimate
૩૮.૯૦ કરોડ/ (૨૩.૬૪ કરોડ est.)USD
+64.58%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
માર્ચ 2025
જૂન 2025
સપ્ટે 2025
ડિસે 2025
Revenue
10.80 કરોડ
14.20 કરોડ
1.02 અબજ
67.80 કરોડ
Cost of goods sold
94.60 કરોડ
81.90 કરોડ
1.01 અબજ
1.23 અબજ
Cost of revenue
94.60 કરોડ
81.90 કરોડ
1.01 અબજ
1.23 અબજ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.20 કરોડ
23.00 કરોડ
26.80 કરોડ
30.80 કરોડ
Operating expense
21.20 કરોડ
23.00 કરોડ
26.80 કરોડ
30.80 કરોડ
Total operating expenses
1.16 અબજ
1.05 અબજ
1.28 અબજ
1.54 અબજ
Operating income
-1.05 અબજ
-90.70 કરોડ
-26.00 કરોડ
-85.70 કરોડ
Other non operating income
40.00 લાખ
90.00 લાખ
-40.00 લાખ
-20.00 લાખ
EBT including unusual items
-96.40 કરોડ
-81.80 કરોડ
-18.70 કરોડ
-79.90 કરોડ
EBT excluding unusual items
-95.70 કરોડ
-81.80 કરોડ
-19.10 કરોડ
-79.70 કરોડ
Income tax expense
70.00 લાખ
70.00 લાખ
1.30 કરોડ
2.70 કરોડ
Effective tax rate
-0.73%
-0.86%
-6.95%
-3.38%
Other operating expenses
-
-
-
-
Net income
-97.10 કરોડ
-82.50 કરોડ
-20.00 કરોડ
-82.60 કરોડ
Net profit margin
-899.07%
-580.99%
-19.68%
-121.83%
Earnings per share
-2.52
-2.13
-0.51
-2.11
Interest and investment income
9.00 કરોડ
8.10 કરોડ
7.30 કરોડ
7.00 કરોડ
Interest expense
-10.00 લાખ
-10.00 લાખ
-
-80.00 લાખ
Net interest expenses
8.90 કરોડ
8.00 કરોડ
7.30 કરોડ
6.20 કરોડ
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.01 અબજ
-85.00 કરોડ
-20.80 કરોડ
-79.00 કરોડ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer